Regina E. Herzlinger offers a prescription for how the NHS, and the United States, could benefit from the Swiss system of healthcare.

Can we all be assured of receiving the healthcare services we need at a price the economy can afford? In the UK the answer is a resounding No.

A recent report showed that Britain ranks last among the five largest European countries in its uptake of cancer drugs, which may account for its low five-year survival rates for diseases such as breast cancer – 78.4 per cent in the UK compared with 90.1 per cent in the US.